New CDC Director Mandy Cohen Thinks Pregnancy is a Disease and Abortion is the Cure
Life News
Source: lifenews.com
Page 38 - Risk Evaluation News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Risk Evaluation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Risk Evaluation Today - Breaking & Trending Today
Dechert Re:Torts - Issue 8 | Key Developments in Product Liability and Mass Torts | Dechert LLP
Advances in Videoconferencing Do Not Change the Subpoena Power of the Court - In In re Kirkland, 2023 WL 4777937 (9th Cir. July 27, 2023), the Ninth Circuit held that a...
Source: jdsupra.com
Long-Term Follow-Up Data from Two Phase 3 Studies of CAMZYOS® (mavacamten) Demonstrate Consistent and Durable Response in Patients with Symptomatic Obstructive Hypertrophic Cardiomyopathy (HCM)
Results from VALOR-HCM LTE demonstrated that with longer follow-up, CAMZYOS continued to reduce eligibility for invasive SRT at 56 weeks EXPLORER-LTE data showed sustained improvements in LVOT...
Source: marketscreener.com
Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple Sclerosis
Polpharma Biologics Announces FDA Approval of Tyruko® - First And Only Approved Biosimilar to Tysabri®* for Relapsing Forms of Multiple SclerosisAMSTERDAM, The Netherlands, August 25, 2023 / B3C newswire / -- Polpharma Biologics, an international biotech company dedicated to the development and ma...
Source: pharmiweb.com
FDA Approves First Biosimilar of Natalizumab for the Treatment of Relapsing Multiple Sclerosis
The FDA is the first regulatory agency globally to approve natalizumab-sztn as a biosimilar for natalizumab.
Source: pharmacytimes.com